首页> 外文期刊>Current pharmaceutical design >Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy
【24h】

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy

机译:脓毒症心肌病的线粒体损伤和靶向干预

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Sepsis and septic shock are known to prompt multiple organ failure including cardiac contractile dysfunction, which is typically referred to as septic cardiomyopathy. Among various theories postulated for the etiology of septic cardiomyopathy, mitochondria' injury (both morphology and function) in the heart is perceived as the main culprit for reduced myocardial performance and ultimately heart failure in the face of sepsis.
机译:背景:已知脓毒症和脓肠梗休克提示多种器官衰竭,包括心脏收缩功能障碍,其通常称为脓毒症心肌病。 在为脓毒症心肌病的病因出发的各种理论中,心脏中的线粒体损伤(形态学和功能)被认为是由于在败血症面前降低心肌表现和最终心力衰竭的主要罪魁祸首。

著录项

  • 来源
    《Current pharmaceutical design》 |2019年第18期|共11页
  • 作者单位

    Southern Med Univ Nanfang Hosp Dept Emergency Med Guangzhou 510515 Guangdong Peoples R China;

    Southern Med Univ Nanfang Hosp Dept Emergency Med Guangzhou 510515 Guangdong Peoples R China;

    Southern Med Univ Shunde Hosp Dept Cardiol Foshan 528300 Guangdong Peoples R China;

    Univ Wyoming Coll Hlth Sci Ctr Cardiovasc Res &

    Alternat Med Laramie WY 82071 USA;

    Southern Med Univ Nanfang Hosp Dept Emergency Med Guangzhou 510515 Guangdong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Mitochondria; sepsis; heart; contraction; intervention; heart failure;

    机译:线粒体;败血症;心脏;收缩;干预;心力衰竭;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号